HomeABEO • NASDAQ
Abeona Therapeutics Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | -16.63M | 2.95% |
Net income | -9.29M | 43.99% |
Net profit margin | — | — |
Earnings per share | -0.32 | 34.21% |
EBITDA | -16.13M | -26.85% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 97.72M | 87.11% |
Total assets | 108.93M | 70.20% |
Total liabilities | 64.90M | 31.97% |
Total equity | 44.03M | — |
Shares outstanding | 48.53M | — |
Price to book | 4.88 | — |
Return on assets | -36.32% | — |
Return on capital | -61.31% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -9.29M | 43.99% |
Cash from operations | -16.56M | -79.31% |
Cash from investing | 18.88M | 63.73% |
Cash from financing | 5.31M | -28.83% |
Net change in cash | 7.63M | -21.82% |
Free cash flow | -12.23M | -2,526.14% |
Previous close
$4.68
Day range
$4.51 - $4.83
Year range
$3.05 - $8.45
Market cap
228.84M USD
Avg Volume
461.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1974
Headquarters
Website
Employees
136